Gilead Sciences, Inc.GILDNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank71
3Y CAGR+17.3%
5Y CAGR+23.8%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+17.3%/yr
vs -2.8%/yr prior
5Y CAGR
+23.8%/yr
Recent deceleration
Acceleration
+20.0pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $11.82B | +611.0% |
| 2024 | $1.66B | -78.1% |
| 2023 | $7.61B | +3.8% |
| 2022 | $7.33B | -26.1% |
| 2021 | $9.92B | +143.6% |
| 2020 | $4.07B | -5.0% |
| 2019 | $4.29B | -47.7% |
| 2018 | $8.20B | -41.9% |
| 2017 | $14.12B | -19.9% |
| 2016 | $17.63B | - |